Literature DB >> 2015255

Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers.

K Matsuzaki1, M Harada, S Funakoshi, N Fujii, K Miyajima.   

Abstract

Permeability enhancement of acidic lipid small unilamellar vesicles (dioleoylphosphatidylglycerol, DOPG; dipalmitoylphosphatidylglycerol, DPPG; bovine brain phosphatidylserine, PS) induced by magainins 1 and 2, basic antimicrobial peptides from Xenopus skin, was investigated at 30 degrees C based on leakage of calcein, an entrapped fluorescent marker. Both the peptide concentration and the lipid concentration dependencies of the leakage rate were analyzed to obtain the binding isotherms of the peptides to the membranes and the 'membrane-perturbing activities' of the membrane-bound peptides. For both peptides, the binding affinity was in the order DOPG greater than DPPG greater than PS, which coincided with the zeta potential order (-54, -39, and -9 mV, respectively). An increase in salt concentration of the medium reduced binding and leakage. Electrostatic interactions play a crucial role in the binding process. On the other hand, the membrane-perturbing activity is regulated by membrane fluidity: The fluid membranes (DOPG and PS) were leakier. A circular dichroism study suggested that at least 14 positively charged residues in the N-terminal regions can form amphiphilic helices which interact with the membranes. An even stronger binding of magainin 2 can be explained in terms of more positive charges in its N-terminal region. A tentative model for the magainin-lipid interactions is hypothesized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015255     DOI: 10.1016/0005-2736(91)90366-g

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study.

Authors:  N Uematsu; K Matsuzaki
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Magainin-mediated disruption of stratum corneum lipid vesicles.

Authors:  S Kaushik; A Krishnan; M R Prausnitz; P J Ludovice
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  Barrel-stave model or toroidal model? A case study on melittin pores.

Authors:  L Yang; T A Harroun; T M Weiss; L Ding; H W Huang
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

4.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

5.  Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation.

Authors:  Fang-Yu Chen; Ming-Tao Lee; Huey W Huang
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

6.  Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid-state NMR.

Authors:  Orsolya Toke; R D O'Connor; Thomas K Weldeghiorghis; W Lee Maloy; Ralf W Glaser; Anne S Ulrich; Jacob Schaefer
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 7.  Computational studies of peptide-induced membrane pore formation.

Authors:  Richard Lipkin; Themis Lazaridis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

8.  Mechanism of membrane activity of the antibiotic trichogin GA IV: a two-state transition controlled by peptide concentration.

Authors:  Claudia Mazzuca; Lorenzo Stella; Mariano Venanzi; Fernando Formaggio; Claudio Toniolo; Basilio Pispisa
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

9.  Structure and interactions of magainin antibiotic peptides in lipid bilayers: a solid-state nuclear magnetic resonance investigation.

Authors:  B Bechinger; M Zasloff; S J Opella
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

10.  Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.

Authors:  H Zhao; J P Mattila; J M Holopainen; P K Kinnunen
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.